Bard Peripheral Vascular

Manufacturing · 1-10 Employees

View Company Info for Free

Overview

Phone Number

(800) 321-4254

Revenue

<$5 Million

Industry

Manufacturing Medical Devices & Equipment
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Bard Peripheral Vascular

The clinical study results demonstrated the safety and effectiveness of the LifeStream® Balloon Expandable Vascular Covered Stent for its intended use. As analyzed on a Pre-Specified basis, the primary composite endpoint result was 16.2% (p-value 0.1987). As analyzed on a Post-Hoc basis utilizing 12-month assessments and additional clinical factors, the primary composite endpoint result was 11.6%. 1 As of April 2017. 2 5 mm - 8 mm diameters utilize a 37 mm base stent platform. 9 mm - 12 mm diameters utilize a 38 mm base stent platform. 3 Calculated as the percentage difference between the labeled balloon outer diameter and the actual balloon outer diameter at nominal pressure (NP). Across all balloon sizes, compliance ranged from 0% to 2.4%, with a mean of 1.1% at nominal pressure. Please consult package insert for the LifeStream® Covered Stent compliance chart. 4 Foreshortening is calculated as the difference, represented as a percentage, between the labeled covered stent length in crRead more
Popular SearchesBard Peripheral Vascular IncMike Austin Bard Peripheral Vascular IncSIC Code 38,384NAICS Code 33,339Show more

Is Bard Peripheral Vascular your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Bard Peripheral Vascular

Compare insights from companies similar to Bard Peripheral Vascular, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Bard Peripheral Vascular

<$5M
1-10
Private
-
-
N/A
$9.7M
11-50
Private
-
2007
$8M
11-50
Private
$66M
2014
Robert Giasolli, Founder & Chief Technology Officer & Vice President, Research & Development at Cagent Vascular
Robert GiasolliFounder & Chief Technology Officer & Vice President, Research & Development
$5.3M
11-50
Private
-
1985
<$5M
11-50
Private
<$5M
2013
MA
Michael AllenPresident & CEO
<$5M
11-50
Private
<$5M
2008
<$5M
11-50
Private
-
2013
ME
Malki EpelVice President, Quality Assurance & Regulatory Affairs
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Bard Peripheral Vascular is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Bard Peripheral Vascular is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bard Peripheral Vascular.

Bard Peripheral Vascular Tech Stack

A closer look at the technologies used by Bard Peripheral Vascular

Top Manufacturing Companies

Frequently Asked Questions Regarding Bard Peripheral Vascular

What is Bard Peripheral Vascular's official website?
Bard Peripheral Vascular's official website is www.bardlifestream.com
What is Bard Peripheral Vascular's Revenue?
Bard Peripheral Vascular's revenue is <$5 Million
What is Bard Peripheral Vascular's SIC code?
Bard Peripheral Vascular's SIC: 38,384
What is Bard Peripheral Vascular's NAICS code?
Bard Peripheral Vascular's NAICS: 33,339
How many employees does Bard Peripheral Vascular have?
Bard Peripheral Vascular has 1-10 employees
What industry does Bard Peripheral Vascular belong to?
Bard Peripheral Vascular is in the industry of: Manufacturing, Medical Devices & Equipment
What is Bard Peripheral Vascular competition?
Bard Peripheral Vascular top competitors include: Euphrates Vascular, Cagent Vascular, Embolx, TARYAG MEDICAL
What technology does Bard Peripheral Vascular use?
Some of the popular technologies that Bard Peripheral Vascular uses are: WordPress.org, PHP, MarkMonitor Domain Management, Google Font API
How do I contact Bard Peripheral Vascular?
Bard Peripheral Vascular contact info: Phone number: (800) 321-4254 Website: www.bardlifestream.com
What does Bard Peripheral Vascular do?

The clinical study results demonstrated the safety and effectiveness of the LifeStream® Balloon Expandable Vascular Covered Stent for its intended use. As analyzed on a Pre-Specified basis, the primary composite endpoint result was 16.2% (p-value 0.1987). As analyzed on a Post-Hoc basis utilizing 12-month assessments and additional clinical factors... , the primary composite endpoint result was 11.6%. 1 As of April 2017. 2 5 mm - 8 mm diameters utilize a 37 mm base stent platform. 9 mm - 12 mm diameters utilize a 38 mm base stent platform. 3 Calculated as the percentage difference between the labeled balloon outer diameter and the actual balloon outer diameter at nominal pressure (NP). Across all balloon sizes, compliance ranged from 0% to 2.4%, with a mean of 1.1% at nominal pressure. Please consult package insert for the LifeStream® Covered Stent compliance chart. 4 Foreshortening is calculated as the difference, represented as a percentage, between the labeled covered stent length in crimped condition and the actual stent length measured at both nominal and at rated burst pressure. Across all balloon sizes, foreshortening ranged from -1.5% to 11.6% at nominal pressure, with a mean of 3.5%, and from -0.8% to 11.8% at rated burst pressure, with a mean of 4.6%. Please consult package insert for the LifeStream® Covered Stent foreshortening chart. 5 Acute Technical Success defined as successful deployment of the LifeStream® Covered Stent at the intended location, as determined by the investigator. BOLSTER Clinical Study. Data on file. Bard Peripheral Vascular, Inc., Tempe, AZ. 6 Based on Kaplan-Meier analysis of Freedom from TLR per subject (As Treated Population). BOLSTER Clinical Study. Data on File. Bard Peripheral Vascular, Inc., Tempe, AZ The LIFESTREAM® Balloon Expandable Vascular Covered Stent is indicated for the treatment of atherosclerotic lesions in common and external iliac arteries with reference vessel diameters between 4.5 mm and 12.0 mm, and lesion lengths up to 100 mm. Use in patients with ...Read More

Is Bard Peripheral Vascular a public company?
Bard Peripheral Vascular is private company therefore does not currently have an official ticker symbol
See more information about Bard Peripheral Vascular

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.